Quixabeira, D. C. A. http://orcid.org/0000-0003-2614-3942
Jirovec, E.
Pakola, S. http://orcid.org/0000-0001-6235-8612
Havunen, R.
Basnet, S.
Santos, J. M.
Kudling, T. V. http://orcid.org/0000-0003-4481-1617
Clubb, J. H. A.
Haybout, L.
Arias, V.
Grönberg-Vähä-Koskela, S.
Cervera-Carrascon, V.
Pasanen, A. http://orcid.org/0000-0002-0079-9807
Anttila, M. http://orcid.org/0000-0003-4089-1357
Tapper, J.
Kanerva, A.
Hemminki, A. http://orcid.org/0000-0001-7103-8530
Article History
Received: 13 April 2023
Revised: 19 July 2023
Accepted: 2 August 2023
First Online: 4 September 2023
Competing interests
: AH is a shareholder in Targovax ASA. AH, JMS, and VCC are employees and shareholders in TILT Biotherapeutics. DQ, RH, and JC are employees of TILT Biotherapeutics.
: Collection of human surgical specimens was approved by the Central Hospital Operative Ethics Committee (Helsinki, Finland) under the permit number 120/13/03/02/16. Human samples were only received upon patients´ written informed consent signature, and no personal patient information was accessed or handled by the researchers. The use of animals in the present project was approved by the Experimental Animal Experimental Board (ELLA) of the University of Helsinki and the Provincial Government of Southern Finland (license number ESAVI/12559/2021) and experiment was conducted according with the FELASA guidelines.